| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/20/2006 | WO2004024862A3 Yeast protein expression secretion system |
| 07/20/2006 | WO2003101177A3 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions |
| 07/20/2006 | WO2003084467A3 Epitope constructs comprising antigen presenting cell targeting mechanisms |
| 07/20/2006 | WO2003083045A3 Lambda integrase mediated recombination in plants |
| 07/20/2006 | US20060162027 Transcriptional activators involved in abiotic stress tolerance |
| 07/20/2006 | US20060162026 Expressing TGF-beta proteins in plant plastids |
| 07/20/2006 | US20060162025 Expression cassettes for vascular tissue-preferential expression in plants |
| 07/20/2006 | US20060162024 Compositions and methods for plant genetic modification |
| 07/20/2006 | US20060162023 Plants having changed development and a method for making the same |
| 07/20/2006 | US20060162022 Eukaryotic initiation factor 5A (eIF-5A) for use as tool in identifying modulators which prevent browning in plants; controlling aging in plants; enzyme inhibitors; storage stability; enhanced shelf life; deoxyhypusine synthase (DHS) |
| 07/20/2006 | US20060162021 Enhanced amylose production in plants |
| 07/20/2006 | US20060162020 Promoters for the expression of genes in tagetes |
| 07/20/2006 | US20060162019 Novel plant receptor-like kinases |
| 07/20/2006 | US20060162018 Plant transcriptional regulators of disease resistance |
| 07/20/2006 | US20060162017 Hybrid cotton plants and seeds, and methods and systems of generating same |
| 07/20/2006 | US20060162016 Herbicide resistant rice |
| 07/20/2006 | US20060162015 Inducible deoxyhypusine synthase promoter from maize |
| 07/20/2006 | US20060162013 Promoters functional in plant plastids |
| 07/20/2006 | US20060162012 Inbred maize line NP2467 |
| 07/20/2006 | US20060162011 Rice cultivar ' Banks ' |
| 07/20/2006 | US20060162010 DNA construct comprising polynucleotide having promoter activity; herbicide tolerance gene |
| 07/20/2006 | US20060162009 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 07/20/2006 | US20060162008 Enzymes and polynucleotides encoding the same |
| 07/20/2006 | US20060162007 Bentgrass event asr-368 and compositions and methods for detection thereof |
| 07/20/2006 | US20060162006 Polynucleotides and polypeptides in plants |
| 07/20/2006 | US20060162005 Methods for producing transgenic medaka |
| 07/20/2006 | US20060162004 ADAM-like protease disruptions, compositions and methods related thereto |
| 07/20/2006 | US20060162002 Drug screening; assaying for activators of the heat shock factor 1 (HSF-1) protein, which increases lifespan when overexpressed in an organism; antiaging agents |
| 07/20/2006 | US20060162001 Mammalian grainyhead transcription factors |
| 07/20/2006 | US20060162000 Development and use of a new orthotopic, genetically tractable non-human animal model for liver cancer |
| 07/20/2006 | US20060161995 Chimeric mouse in which at least 85% of the human antibody-producing cells retain the human artificial chromosome Delta HAC or Delta Delta HAC. |
| 07/20/2006 | US20060160997 Tumor-associated antigen specific immunoglobulin fusion for use in diagnosis, prevention and treatment of cell proliferative |
| 07/20/2006 | US20060160994 Containing modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII; for use in the treatment of hemorrhagenic disturbances |
| 07/20/2006 | US20060160981 Phenolic polymer nanotube and producing the same |
| 07/20/2006 | US20060160764 LIMKs as modifiers of p53 pathway and methods of use |
| 07/20/2006 | US20060160760 Modulation of glucocorticoid receptor expression |
| 07/20/2006 | US20060160759 Influenza therapeutic |
| 07/20/2006 | US20060160757 RNA interference mediated inhibition hairless of (HR) gene expression using short interfering nucleic acid (siNA) |
| 07/20/2006 | US20060160731 Peptide nucleic acids |
| 07/20/2006 | US20060160730 Administering pro-adrenomedullin N-terminal 20 peptide to induce neovascularization; use in treating coronary artery disease, peripheral vascular disease, and wounds; skin and organ (including heart) grafts |
| 07/20/2006 | US20060160723 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 07/20/2006 | US20060160700 Nadh-dependent cytochrome b5 reductase as target for herbicides |
| 07/20/2006 | US20060160223 Plasmid vectors for transformation of filamentous fungi |
| 07/20/2006 | US20060160222 Modifying DNA recombination and repair |
| 07/20/2006 | US20060160221 chamber which comprises at least one inlet line comprising at least one opening arranged close to said electrode; due to this specific arrangement the inner space of said chamber can be effectively rinsed, even in a closed state and under aseptic conditions |
| 07/20/2006 | US20060160220 Retroviral vectors with introns |
| 07/20/2006 | US20060160219 Method of transferring mutation into target nucleic acid |
| 07/20/2006 | US20060160218 Transdifferentiation of cells and tissues |
| 07/20/2006 | US20060160217 Novel nucleic acids from sesame plants |
| 07/20/2006 | US20060160215 Methods of developing a stem cell line |
| 07/20/2006 | US20060160211 Transgenic mice containing, cGMP phosphodiesterase gene disruptions |
| 07/20/2006 | US20060160202 Bacterial artificial chromosome vector for use in the propagation and transfer of genetic material; equine herpesvirus (EHV) |
| 07/20/2006 | US20060160195 Novel vector |
| 07/20/2006 | US20060160194 Process for the production of biodegradeable, functionalised polymer particles, and use thereof as pharmaceutical supports |
| 07/20/2006 | US20060160193 Suitable for use in the manufacture of microbial oils enriched in omega fatty acids in oleaginous yeast (e.g., Yarrowia lipolytica) |
| 07/20/2006 | US20060160192 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family having a pathway of glycogen biosynthesis disrupted |
| 07/20/2006 | US20060160179 Filamentous fungal host cells to produce glycans without mannosylphosphate residues, therapy |
| 07/20/2006 | US20060160178 Methods of generating antibody diversity in vitro |
| 07/20/2006 | US20060160175 Compositions of orthogonal leucyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 07/20/2006 | US20060160173 Compared with a homoserine transsuccinylase wild-type enzyme, exhibits a reduced sensitivity toward L-methionine or S-Adenosylmethionine, with the wild-type enzyme possessing an amino acid sequence which comprises a constituent sequence TyrGlnXaaThrPro, with the Thr at position 297 onward being replaced |
| 07/20/2006 | US20060160172 Sqs gene |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060160154 Materials and methods for detection and treatment of breast cancer |
| 07/20/2006 | US20060160150 Solid phase synthesis; antibodies; kits |
| 07/20/2006 | US20060160147 Recombinant cell line |
| 07/20/2006 | US20060160146 Method of screening compound affecting amyloid beta production |
| 07/20/2006 | US20060160145 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs |
| 07/20/2006 | US20060160143 Mitogenic oxygenases |
| 07/20/2006 | US20060160140 Human nuclear receptor protein nNR7-1 |
| 07/20/2006 | US20060160130 Recombinant RSV virus expression systems and vaccines |
| 07/20/2006 | US20060160129 Methods of producing a library and methods of selecting polynucleotides of interest |
| 07/20/2006 | US20060160128 Novel adenosine deaminase homolog |
| 07/20/2006 | US20060160126 90 human secreted proteins |
| 07/20/2006 | US20060160123 For increasing stability of short interfering RNA molecule when in contact with biological sample, and reducing off-target effects/interferon responsiveness; ribonuclease stability |
| 07/20/2006 | US20060160117 Polynucleotide motor, a motor system, their preparation and uses |
| 07/20/2006 | US20060160113 Terminal-phosphate-labeled nucleotides |
| 07/20/2006 | US20060160110 Methods of designing small interfering RNAs, antisense polynucleotides, and other hybridizing polynucleotides |
| 07/20/2006 | US20060160106 Using peptide nucleic acid probes to detect chromosome aberrations in eukaryotic cells |
| 07/20/2006 | US20060160098 Polymeric label molecules |
| 07/20/2006 | US20060160097 Amplification reaction vessel, and method of manufacturing the same |
| 07/20/2006 | US20060160091 Polynucleotides encoding a class II cytokine receptor |
| 07/20/2006 | US20060160090 Composition splice variants and methods relating to cancer specific genes and proteins |
| 07/20/2006 | US20060160085 Novel buffer formulations for isolating purifying and recovering long-chain and short-chain nucleic acids |
| 07/20/2006 | US20060160084 Process for amplifying nucleic acid |
| 07/20/2006 | US20060160082 Novel genes and proteins encoded thereby |
| 07/20/2006 | US20060160080 Avian sex determination method |
| 07/20/2006 | US20060160078 Lateral flow assay device and method |
| 07/20/2006 | US20060160076 Methods of treating and diagnosing diabetes with cx3cr1 modulators |
| 07/20/2006 | US20060160075 nucleotides having a removable labels, used in polynucleotide sequencing |
| 07/20/2006 | US20060160073 Efficient algorithm for PCR testing of blood samples |
| 07/20/2006 | US20060160072 using modified vaccinia topoisomerase enzyme containing an affinity tag to facilitate purification of protein-DNA complexes away from unbound DNA; ligating duplex DNAs; cloning DNA by introducing into a cell ligated duplex DNA |
| 07/20/2006 | US20060160067 GBV-B polynucleotide coding a virus having domain III of the 5' neurotrophin region from a hepatitis C virus 5' NTR, and at least part of a structural or non-structural protein coding region of HCV; viral expression construct; infectious GBV-B molecular clone |
| 07/20/2006 | US20060159764 for delivery of nucleic acids for example; noncovalently associating molecules with the polyion in a solution outside a cell; adding a crosslinker that contains a disulfide bond and forms covalent linkages between moieties of the molecules in the presence of the polyion, to form a complex |
| 07/20/2006 | US20060159738 Cationic liposomes and methods of use |
| 07/20/2006 | US20060159737 Pharmaceutical compositions for local administration |
| 07/20/2006 | US20060159709 Recombinant high molecular weight major outer membrane protein of moraxella |
| 07/20/2006 | US20060159707 Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses |
| 07/20/2006 | US20060159706 Novel insertion sites in pox vectors |
| 07/20/2006 | US20060159704 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and other infectious agents |
| 07/20/2006 | US20060159703 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |